Methods for selective immunomodulation using pimecrolimus

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/436 (2006.01) A61K 31/353 (2006.01) A61K 31/439 (2006.01) A61K 31/4745 (2006.01) A61K 31/56 (2006.01) A61K 45/06 (2006.01) A61P 1/00 (2006.01) A61P 11/06 (2006.01) A61P 29/00 (2006.01) A61P 37/02 (2006.01)

Patent

CA 2442969

This invention relates to methods to produce selective immunomodulation in epithelial tissues to treat epithelial inflammatory disorders. This invention provides methods for the use of pimecrolimus to treat epithelial inflammatory disorders, including asthma and inflammatory bowel disease while minimizing systemic side effects.

La présente invention concerne des procédés permettant de réaliser une immunomodulation sélective de tissus épithéliaux de façon à traiter des troubles inflammatoires épithéliaux. L'invention concerne plus particulièrement des procédés permettant d'utiliser le pimécrolimus pour traiter des troubles inflammatoires épithéliaux, y compris l'asthme et les affections inflammatoires intestinales tout en minimisant les effets secondaires systémiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods for selective immunomodulation using pimecrolimus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for selective immunomodulation using pimecrolimus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for selective immunomodulation using pimecrolimus will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1415701

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.